Phospho-β-catenin accumulation in Alzheimer's disease and in aggresomes attributable to proteasome dysfunction

被引:56
作者
Ghanevati, M
Miller, CA [1 ]
机构
[1] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA
[2] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA
[3] Univ So Calif, Keck Sch Med, Program Neurosci, Los Angeles, CA 90033 USA
关键词
Aggresome; Alzheimer's disease; granulovacuolar degeneration; phospho-beta-catenin; proteasome;
D O I
10.1385/JMN:25:1:079
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Accumulation of cytoplasmic inclusion bodies in many neurodegenerative diseases, including Alzheimer's disease (AD), might result from dysfunction of the ubiquitin-proteasome system. This system degrades many cellular proteins, including beta-catenin, a member of the Wnt signaling pathway, and a presenilin-1-interacting protein. Phosphorylation of beta-catenin marks it for ubiquitination and rapid proteasomal degradation. We found phospho-beta-catenin accumulated as detergent-insoluble, punctate, cytoplasmic inclusions in hippocampal pyramidal neurons more abundantly in AD than in aged controls. In AD, beta-catenin was ubiquitin conjugated, thus suggesting impaired proteasome-dependent degradation. Phospho-beta-catenin was partially sequestered within granulovacuolar degeneration bodies but not in lysosomes, indicating sequestration within autophagosomes. Exposure of neuronal cultures to proteasome inhibitors induced formation of detergent-insoluble, phospho-beta-catenin-positive cytoplasmic inclusions that coalesced into aggresomes and colocalized with gamma-tubulin and vimentin These aggregates were associated with apoptotic cell death and with activation of caspase-3, c-Jun-N-terminal kinases, and c-Jun. These findings suggest that phospho-beta-catenin accumulation in AD might result from impaired proteasome function.
引用
收藏
页码:79 / 94
页数:16
相关论文
共 62 条
[1]   beta-catenin is a target for the ubiquitin-proteasome pathway [J].
Aberle, H ;
Bauer, A ;
Stappert, J ;
Kispert, A ;
Kemler, R .
EMBO JOURNAL, 1997, 16 (13) :3797-3804
[2]   Axin-mediated CKI phosphorylation of β-catenin at Ser 45:: a molecular switch for the Wnt pathway [J].
Amit, S ;
Hatzubai, A ;
Birman, Y ;
Andersen, JS ;
Ben-Shushan, E ;
Mann, M ;
Ben-Neriah, Y ;
Alkalay, I .
GENES & DEVELOPMENT, 2002, 16 (09) :1066-1076
[3]   Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease [J].
Augustinack, JC ;
Schneider, A ;
Mandelkow, EM ;
Hyman, BT .
ACTA NEUROPATHOLOGICA, 2002, 103 (01) :26-35
[4]   Impairment of the ubiquitin-proteasome system by protein aggregation [J].
Bence, NF ;
Sampat, RM ;
Kopito, RR .
SCIENCE, 2001, 292 (5521) :1552-1555
[5]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[6]   Impairment of proteasome structure and function in aging [J].
Carrard, G ;
Bulteau, AL ;
Petropoulos, I ;
Friguet, B .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2002, 34 (11) :1461-1474
[7]   NEUROBLASTOMA X SPINAL-CORD (NSC) HYBRID CELL-LINES RESEMBLE DEVELOPING MOTOR NEURONS [J].
CASHMAN, NR ;
DURHAM, HD ;
BLUSZTAJAN, JK ;
ODA, K ;
TABIRA, T ;
SHAW, IT ;
DAHROUGE, S ;
ANTEL, JP .
DEVELOPMENTAL DYNAMICS, 1992, 194 (03) :209-221
[8]   Evidence for proteasome involvement in polyglutamine disease:: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro [J].
Chai, YH ;
Koppenhafer, SL ;
Shoesmith, SJ ;
Perez, MK ;
Paulson, HL .
HUMAN MOLECULAR GENETICS, 1999, 8 (04) :673-682
[9]   The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders [J].
Chung, KKK ;
Dawson, VL ;
Dawson, TM .
TRENDS IN NEUROSCIENCES, 2001, 24 (11) :S7-S14
[10]  
Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO